Clarient, Inc. (NASDAQ:CLRT)
CAPS Rating:
The Company is an advanced oncology diagnostics technology and services company. It combines innovative technologies and meaningful test results to improve outcomes of patients suffering from cancer.
RSS Headlines
Fool UK
Recs
CLARIENT,INC Will be cash positive in the fourth quarter and will have double dighit growth in year 2007.